Latest Regulatory Compliance News

Wrkr Ltd has completed a pivotal pilot of its employer services platform with Rest and MUFG Retirement Services, setting the stage for streamlined Payday Super implementation ahead of the July 2026 deadline.

Harvest Technology Group reports it is one year ahead of its 3-Year Pathway to Profit plan, forecasting a significant reduction in EBITDA loss for FY25 and unveiling plans for its AI-powered NEON platform launch in 1H26.

Koba Resources has completed a $600,000 placement of shares at 3.6 cents each, sweetened with free options exercisable at 8 cents until mid-2028. The move strengthens the company’s capital base without triggering extensive disclosure requirements.

Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.

Monash IVF Group has affirmed its compliance with ASX continuous disclosure rules following a clinical incident involving an embryo transfer error at its Clayton laboratory. The company clarified the materiality and timing of its disclosures in response to ASX inquiries.

Western Gold Resources has confirmed a binding toll milling agreement with Wiluna Mining Corporation, explaining recent unusual trading activity in its shares.

HeraMED has partnered with RMIT University and the Digital Health CRC to develop AI-driven maternity care models focused on culturally diverse populations, aiming to improve pre-term delivery risk prediction and personalised care.

ASIC has initiated a comprehensive compliance inquiry into ASX’s governance, risk management, and operational capabilities, folding its previous CHESS incident probe into this broader review. ASX pledges full cooperation amid ongoing technology upgrades.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Marimaca Copper has successfully closed the second tranche of a US$17.7 million private placement, bolstering funds to advance its flagship copper project in Chile. This capital injection marks a significant step in progressing the Marimaca Copper Project’s feasibility and exploration activities.

Dundee Precious Metals has agreed to acquire Adriatic Metals in a recommended £924 million share and cash offer, valuing Adriatic at approximately US$1.25 billion and delivering a premium of over 47% to recent trading prices.